MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.165
+0.095 (3.09%)
At close: Apr 6, 2026, 4:00 PM EDT
3.180
+0.015 (0.47%)
After-hours: Apr 6, 2026, 4:10 PM EDT

MacroGenics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
57.22182.84100.96108.88123.47
Short-Term Investments
132.718.83128.8545.46120.15
Cash & Short-Term Investments
189.91201.67229.81154.35243.62
Cash Growth
-5.83%-12.24%48.89%-36.64%-10.61%
Accounts Receivable
13.374.3110.3756.2210.39
Inventory
7.91-1.221.454.39
Other Current Assets
8.7511.519.9510.1621.17
Total Current Assets
219.94217.49251.34222.18279.56
Net Property, Plant & Equipment
35.5242.6145.6956.9154.29
Other Long-Term Assets
1.391.561.391.381.4
Total Assets
256.85261.66298.42280.47335.25
Accounts Payable
4.795.016.444.915.5
Accrued Expenses
22.2329.3324.242933.76
Current Portion of Leases
5.184.863.784.734.68
Unearned Revenue
10.9216.3221.659.9920.65
Total Current Liabilities
43.1255.5356.1148.6174.58
Long-Term Leases
31.5932.630.230.1120.79
Other Long-Term Liabilities
126.5657.4759.559.740.26
Total Long-Term Liabilities
158.1490.0789.789.8421.05
Total Liabilities
201.26145.6145.81138.4695.63
Common Stock
0.630.630.620.620.61
Additional Paid-in Capital
1,2991,2851,2551,2351,213
Accumulated Other Comprehensive Income
0.030-0.01-0.01-0.06
Retained Earnings
-1,244-1,170-1,103-1,094-973.94
Shareholders' Equity
55.59116.06152.61142.01239.62
Total Liabilities & Equity
256.85261.66298.42280.47335.25
Total Debt
36.7637.4633.9734.8325.47
Net Cash (Debt)
153.15164.21195.83119.51218.15
Net Cash Growth
-6.73%-16.15%63.86%-45.21%-10.33%
Net Cash Per Share
2.422.623.161.953.64
Book Value
55.59116.06152.61142.01239.62
Book Value Per Share
0.881.852.462.314.00
Tangible Book Value
55.59116.06152.61142.01239.62
Tangible Book Value Per Share
0.881.852.462.314.00
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q